Israel’s Galmed Wins South Korea Patent for New Liver Disease Combination Therapy
Galmed Pharmaceuticals secures South Korea patent for innovative liver disease combination therapy, extending global protection.
Israel-South Korea ties
Israeli, South Korean Startups Collaborate on Gene-Edited Soybeans
Israeli ag-biotech company PlantArcBio and South Korean gene editing company ToolGen announced on Wednesday a strategic collaboration to develop a gene-edited soybean with enhanced herbicide tolerance.